ðŸ§¬ Permanent Seed Brachytherapy â€” Possible Risks

Bruising and discolouration of the skin behind the scrotum (perineum)
â†’ Happens in almost all patients.
(This usually fades on its own.)

Difficulty passing urine (urinary retention)
â†’ Affects 1 in 7 to 1 in 10 patients (10â€“15%).
May require a temporary catheter, or sometimes learning to pass a small tube yourself.

Erectile dysfunction (impotence)
â†’ Affects 1 in 2 to 1 in 5 patients (20â€“40%).
Erections may become weaker or difficult to maintain due to nerve changes.

Rectal discomfort, sometimes with blood or mucus from the bowel
â†’ Happens in 1 in 10 to 1 in 50 patients (2â€“10%).

Temporary urine leakage (incontinence)
â†’ Happens in 1 in 10 to 1 in 50 patients (2â€“10%).

Bladder infection requiring antibiotics
â†’ Happens in 1 in 10 to 1 in 50 patients (2â€“10%).

Persistent difficulty passing urine (may need prostate surgery)
â†’ Happens in 1 in 10 to 1 in 50 patients (2â€“10%).

Cancer not fully responding (may need further treatment such as surgery or hormone therapy)
â†’ Happens in 1 in 10 to 1 in 50 patients (2â€“10%).

Permanent urine leakage (incontinence)
â†’ Happens in 1 in 50 to 1 in 250 patients (0.4â€“2%).

Damage to the rectum that may require a temporary colostomy
â†’ Happens in 1 in 50 to 1 in 250 patients (0.4â€“2%).

Anaesthetic or heart/lung complications (e.g. chest infection, blood clot, stroke, heart attack, or death)
â†’ Happens in 1 in 50 to 1 in 250 patients (0.4â€“2%).

New radiation-induced cancer years after treatment
â†’ Risk of about 1% per 10 years.